IDEXX Laboratories news
The WiseView Research desk's stories that name IDEXX Laboratories, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The IDXX page →
- HeadlineGear Up for Idexx (IDXX) Q3 Earnings: Wall Street Estimates for Key Metrics
- HeadlineIdexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
- Company earningsThermo Fisher Scientific tops Q3 estimates, but shares slide premarket
Thermo Fisher beat EPS and revenue estimates for Q3, yet the stock fell before the open on October 21, 2026.
- HeadlineWill Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
- HeadlineThese 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- HeadlineIdexx (IDXX) Moves to Buy: Rationale Behind the Upgrade
- CongressRo Khanna sold $1,001 - $15,000 of IDXX
- CongressRo Khanna sold $15,001 - $50,000 of IDXX
- CongressRo Khanna bought $1,001 - $15,000 of IDXX
- HeadlineIDEXX Laboratories to Release 2026 Third Quarter Financial Results
- HeadlineChicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
- CongressRo Khanna bought $1,001 - $15,000 of IDXX
- CongressApril Delaney sold $1,001 - $15,000 of IDXX
- CongressApril Delaney sold $1,001 - $15,000 of IDXX
- CongressApril Delaney sold $1,001 - $15,000 of IDXX
- CongressApril Delaney sold $1,001 - $15,000 of IDXX
Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.